Bgm (BGM) Cash & Equivalents (2019 - 2025)
Bgm's (BGM) quarterly Cash & Equivalents came in at $9.8 million in Q3 2025, little changed year-on-year from $9.8 million in Q3 2024, and down 8.2% on a QoQ basis from $10.7 million in Q1 2025.
Bgm (BGM) Cash & Equivalents (2019 - 2025) Analysis & Trends
Bgm (BGM) has 7 years of Cash & Equivalents data on file, last reported at $9.8 million in Q3 2025.
- On a quarterly basis, Cash & Equivalents changed 0.02% year-over-year to $9.8 million in Q3 2025; TTM through Sep 2025 was $9.8 million, a 0.02% change from a year earlier, with the FY2025 full-year figure at $9.8 million, changed 0.02% from the prior year.
- Cash & Equivalents for Q3 2025 stood at $9.8 million, down from $10.7 million in the prior quarter.
- Over the last five years, Cash & Equivalents for BGM reached as high as $16.7 million in Q1 2022 and fell as low as $20.31 in Q1 2021.
- Historically, Cash & Equivalents has averaged $9.9 million across 5 years, with a median of $10.1 million in 2024.
- Across the five-year window, Cash & Equivalents jumped 82048261.17% in 2022 and sank 47.79% in 2023, its largest moves.
- Year by year, Cash & Equivalents stood at $10.5 million in 2021, then jumped by 36.8% to $14.3 million in 2022, then sank by 47.79% to $7.5 million in 2023, then jumped by 31.31% to $9.8 million in 2024, then rose by 0.02% to $9.8 million in 2025.
- Per Business Quant data, the three most recent Cash & Equivalents figures were $9.8 million in Q3 2025, $10.7 million in Q1 2025, and $9.8 million in Q3 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - | 1.76 Bn |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn | 3.74 Bn |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn | 1.94 Bn |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn | 3.79 Bn |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn | 1.28 Bn |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - | 3.97 Mn |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn | 1.80 Bn |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn | 266.50 Mn |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn | 428.00 Mn |
| 10 | Bgm | 33.55 Mn | 23.73 Mn | - | 9.82 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 9.82 Mn |
| Mar 31, 2025 | 10.70 Mn |
| Sep 30, 2024 | 9.82 Mn |
| Mar 31, 2024 | 10.35 Mn |
| Sep 30, 2023 | 7.48 Mn |
| Mar 31, 2023 | 9.71 Mn |
| Sep 30, 2022 | 14.32 Mn |
| Mar 31, 2022 | 16.67 Mn |
| Sep 30, 2021 | 10.47 Mn |
| Mar 31, 2021 | 20.31 |
| Sep 30, 2020 | 11.87 Mn |
| Sep 30, 2019 | 4.59 Mn |